Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1328-1335
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1328
Table 2 Correlation of GLI1 expression with clinicopathological data of patients undergoing radical surgery for colorectal carcinoma
Grouping
n
GLI1 positive (n = 65), n (%)
GLI1 negative (n = 38), n (%)
χ2
P value
Sex0.4030.526
    Male5335 (53.85)18 (47.37)
    Female5030 (46.15)20 (52.63)
Age3.5040.061
    < 60 yr old4222 (33.85)20 (53.63)
    ≥ 60 yr old6143 (66.15)18 (47.37)
Tumor location0.2210.638
    Colon4326 (40.00)17 (44.74)
    Rectum6039 (60.00)21 (55.26)
Differentiation degree0.5520.458
    High differentiation2313 (20.00)10 (26.32)
    Medium–low differentiation8052 (80.00)28 (73.68)
Pathological staging3.0860.079
    I–II4826 (40.00)22 (57.89)
    III–IV5539 (60.00)16 (42.11)
Lymph node metastasis5.2330.022
    Positive5844 (67.69)17 (44.74)
    Negative4521 (32.31)21 (55.26)